Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,506.00
(
0.28%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.36
(
0.00%
)
Bitcoin
73,825.77
(
0.10%
)
News Focus
News Focus
Post# of 518960
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

dia76ca

Send PM Follow Ignore
Followers 58
Posts 5951
Boards Moderated 0
Alias Born 12/13/2004

dia76ca

Re: dia76ca post# 155531

Tuesday, 07/03/2018 5:25:17 PM

Tuesday, July 03, 2018 5:25:17 PM

Post# of 518960
Looking at the Anavex May 2018 presentation I note that they say they have in development 3-71 and 1-41 both targeting Alzheimer's! It would be interesting to know if these are designed to complement the lead drug!

See slide 6 at http://www.anavex.com/wp-content/uploads/2018/05/Anavex-Presentation-May-2018-1.pdf

"The refusal of the real is the number one dogma of our time" Rene Girard

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News